IFNAR2-IL10RB
Basic information
Region (hg38): 21:33229892-33297160
Links
Phenotypes
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFNAR2-IL10RB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 0 | 0 |
Variants in IFNAR2-IL10RB
This is a list of pathogenic ClinVar variants found in the IFNAR2-IL10RB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-33237200-G-A | Mortality risk in patients with severe coronavirus disease (COVID-19) • Associated with severe COVID-19 disease | Uncertain significance; association (Jul 01, 2023) | ||
21-33241936-A-G | Uncertain significance (Jul 26, 2022) | |||
21-33241945-T-C | Hepatitis B virus, susceptibility to • Immunodeficiency 45 • Mortality risk in patients with severe coronavirus disease (COVID-19) • not specified | Benign (Feb 03, 2025) | ||
21-33241949-C-G | not specified | Uncertain significance (Jul 12, 2023) | ||
21-33241950-T-A | Associated with severe COVID-19 disease | Uncertain significance (Jul 01, 2023) | ||
21-33241950-T-G | Immunodeficiency 45 • Mortality risk in patients with severe coronavirus disease (COVID-19) • not specified | Benign (Feb 03, 2025) | ||
21-33241954-G-C | not specified | Uncertain significance (Apr 17, 2024) | ||
21-33241955-A-T | Uncertain significance (Aug 19, 2022) | |||
21-33241958-A-G | Likely benign (Jul 19, 2022) | |||
21-33241958-A-T | Likely benign (Nov 16, 2024) | |||
21-33241961-T-G | Likely benign (Aug 14, 2024) | |||
21-33241966-T-G | not specified | Uncertain significance (Nov 26, 2024) | ||
21-33241975-T-C | Uncertain significance (Jul 04, 2022) | |||
21-33241987-G-A | Likely benign (Dec 27, 2023) | |||
21-33241987-G-C | Likely benign (Dec 05, 2024) | |||
21-33241988-C-T | Likely benign (Nov 18, 2023) | |||
21-33241994-A-G | Likely benign (Sep 21, 2021) | |||
21-33241994-A-T | Likely benign (Mar 06, 2022) | |||
21-33241995-T-C | Likely benign (Jun 06, 2023) | |||
21-33241996-C-T | Likely benign (Apr 29, 2024) | |||
21-33243657-G-A | Likely benign (Sep 08, 2024) | |||
21-33243676-A-G | Uncertain significance (Oct 03, 2023) | |||
21-33243682-G-T | not specified | Uncertain significance (Sep 09, 2022) | ||
21-33243683-C-T | Likely benign (Oct 16, 2024) | |||
21-33243686-C-T | Likely benign (Mar 07, 2024) |
GnomAD
Source:
dbNSFP
Source: